• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 III; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 III; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Model Number FT4 G3
Device Problem Incorrect Measurement (1383)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2022
Event Type  malfunction  
Event Description
The initial reporter stated they received discrepant results for two patient samples tested with elecsys ft3 iii (ft3) and elecsys ft3 iii ver.2 (ft3 v2) on two cobas 8000 e 602 module analyzers.The first sample also had discrepant results for the elecsys ft4 iii assay on both e 602 analyzer.The second sample also had discrepant ft3 and ft3 v2 results when tested on a cobas e 411 immunoassay analyzer.This medwatch will apply to the ft4 assay.Please refer to the medwatch with patient identifier (b)(6) for information related to the ft3 assay and refer to the medwatch with patient identifier (b)(6) for information related to the ft3 v2 assay.Both samples were initially tested on the customer's e 602 analyzer in (b)(6) 2022.The specific date of the event is not known.The initial values were reported outside of the laboratory.The samples were then tested on the customer's e 602 analyzer on (b)(6) 2022 as part of correlation testing for the ft3 and ft3 v2 assays.There were differences between the ft3 and ft3 v2 measurements.The samples were then provided for investigation, where they were tested on a second e 602 analyzer.The second sample was also tested on an e411 analyzer during the investigation.The first sample was repeated on a centaur analyzer.The serial number of the customer's e 602 analyzer is (b)(4).The ft4 reagent lot number and expiration date used on this analyzer were requested, but not provided.The serial number of the e 602 analyzer used for investigation is (b)(4).The ft4 reagent used on this analyzer was lot 579081, with an expiration date of 31-oct-2022.
 
Manufacturer Narrative
Na.
 
Manufacturer Narrative
Sample 2 was repeated on the siemens centaur analyzer, resulting in the following values: tsh = 2.420 uiu/ml, ft4 = 1.31 ng/dl, ft3 = 3.3 pg/ml.
 
Manufacturer Narrative
For sample 1, there was no remaining volume available for further investigations.For sample 1 (measured with the ft4 assay), the investigation could not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 III
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key13838752
MDR Text Key294393436
Report Number1823260-2022-00775
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFT4 G3
Device Catalogue NumberASKU
Device Lot NumberASKU, 579081
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/01/2022
Initial Date FDA Received03/21/2022
Supplement Dates Manufacturer Received03/22/2022
05/17/2022
Supplement Dates FDA Received04/14/2022
06/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient SexFemale
-
-